Weed (BUDZ) Net Cash Flow Growth (1y) (2011 - 2026)
Weed (BUDZ) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | -121.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.72% |
| Dec 31, 2025 | -78.73% |
| Sep 30, 2025 | 48.96% |
| Jun 30, 2025 | 103.83% |
| Mar 31, 2025 | 16.83% |
| Dec 31, 2024 | 143.37% |
| Sep 30, 2024 | -101.47% |
| Jun 30, 2024 | 25.25% |
| Mar 31, 2024 | 14.65% |
| Dec 31, 2023 | -61.13% |
| Sep 30, 2023 | 332.15% |
| Jun 30, 2023 | 75.43% |
| Mar 31, 2023 | -1,567.39% |
| Dec 31, 2022 | -1,326.26% |
| Sep 30, 2022 | -690.64% |
| Jun 30, 2022 | -8,967.41% |
| Mar 31, 2022 | -52.66% |
| Dec 31, 2021 | 111.64% |
| Sep 30, 2021 | -122.69% |
| Jun 30, 2021 | -306.96% |